SPC25 expression is higher in PrC samples than in paired normal prostate tissues, and PrC patients with high SPC25 have a lower OS rate compared to those with low SPC25. SPC25+ cells form more tumor spheres, exhibit stronger resistance to docetaxel-induced apoptosis, and generate larger tumors with higher frequency in adoptive transfer. This evidence concerns the gene SPC25 and neoplasm.